Literature DB >> 20676627

Functional and structural characterization of soluble recombinant epsilon toxin of Clostridium perfringens D, causative agent of enterotoxaemia.

Deepika Dayal Mathur1, Sachin Deshmukh, Himani Kaushik, Lalit C Garg.   

Abstract

Clostridium perfringens types B and D are responsible for enterotoxaemia, one of the major causes of cattle mortality and is therefore of great economic concern. The epsilon toxin produced by the organism is the major antigenic determinant and has been directly implicated for the disease causation. In the present paper, we evaluated the biological activity of the recombinant epsilon toxin (rEtx) produced as soluble protein in Escherichia coli. The rEtx was purified to near homogeneity by a one-step anion-exchange chromatography. The immunological identity of purified rEtx was confirmed by Western blotting using a monoclonal antibody against the native toxin. The rEtx formed heptamer in the Madin-Darby canine kidney (MDCK) cells and synaptosomal membrane of mouse brain and was cytotoxic to the MDCK cells with a CT(50) of 30 ng/ml. The rEtx was highly stable and its thermostability profile related well with its biological activity. The rEtx was purified in large amounts and exhibited all the properties of native toxin and therefore can be used for the development of vaccine against the pathogen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676627     DOI: 10.1007/s00253-010-2785-y

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  9 in total

1.  A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.

Authors:  Qing Li; Wenwen Xin; Shan Gao; Lin Kang; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2013-07-08       Impact factor: 3.452

2.  Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin.

Authors:  Susan L Robertson; Jihong Li; Francisco A Uzal; Bruce A McClane
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

Review 3.  Regulation of DNA repair by non-coding miRNAs.

Authors:  Venkateswaran Natarajan
Journal:  Noncoding RNA Res       Date:  2016-11-05

Review 4.  Role of let-7 family microRNA in breast cancer.

Authors:  Chadrashekar Kagepura Thammaiah; Shankar Jayaram
Journal:  Noncoding RNA Res       Date:  2016-11-04

5.  Evaluation of plant-produced <i>Clostridium perfringens</i> type D <i>epsilon</i> toxoid in a vaccine against enterotoxaemia in sheep.

Authors:  Tinyiko Mokoena; Ereck Chakauya; Michael Crampton; Boet Weyers; Malefa Tselanyane; Tsepo Tsekoa; Rachel Chikwamba
Journal:  Onderstepoort J Vet Res       Date:  2017-04-25       Impact factor: 1.792

6.  Pathogenic Pore Forming Proteins of Plasmodium Triggers the Necrosis of Endothelial Cells Attributed to Malaria Severity.

Authors:  Abhishek Shivappagowdar; Swati Garg; Akriti Srivastava; Rahul S Hada; Inderjeet Kalia; Agam P Singh; Lalit C Garg; Soumya Pati; Shailja Singh
Journal:  Toxins (Basel)       Date:  2021-01-15       Impact factor: 4.546

7.  Design of a chitosan-based nano vaccine against epsilon toxin of Clostridium perfringens type D and evaluation of its immunogenicity in BALB/c mice.

Authors:  Farnaz Poorhassan; Fahimeh Nemati; Parvaneh Saffarian; Seyed Ali Mirhosseini; Mohammad Javad Motamedi
Journal:  Res Pharm Sci       Date:  2021-10-15

8.  Structural and Functional Characterization of Recombinant Interleukin-10 from Indian Major Carp Labeo rohita.

Authors:  Sweta Karan; Pujarini Dash; Himani Kaushik; Pramoda K Sahoo; Lalit C Garg; Aparna Dixit
Journal:  J Immunol Res       Date:  2016-09-01       Impact factor: 4.818

9.  A small bioactive glycoside inhibits epsilon toxin and prevents cell death.

Authors:  Abhishek Shivappagowdar; Soumya Pati; Chintam Narayana; Rajagopal Ayana; Himani Kaushik; Raj Sah; Swati Garg; Ashish Khanna; Jyoti Kumari; Lalit Garg; Ram Sagar; Shailja Singh
Journal:  Dis Model Mech       Date:  2019-10-10       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.